These results are partially consistent with a previous clinical trial in which blood ALT, gamma-glutamyl transferase, and TG levels of patients with NAFLD were significantly reduced by 30 days of 2 g day−1 treatment with Korean red ginseng compared to placebo controls [60]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.